1. 赫捷 中国 中国医学科学院 中国科学院院士 Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for local..
2. 赫捷 中国 中国医学科学院 中国科学院院士 Comparison of neoadjuvant nab-paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for..
3. 陈香美 中国 解放军总医院 中国工程院院士 Luteolin can ameliorate renal interstitial fibrosis-induced renal anaemia through the SIRT1/FOXO3 pa..
4. 刘芝华 中国 中国医学科学院 Progenitor-like exhausted SPRY1+CD8+T cells potentiate responsiveness to neoadjuvant PD-1 blockade i..
5. 何建行 中国 广州医科大学 院长 A surgical Decision-making scoring model for spontaneous ventilation- and mechanical ventilation-vid..
6. Yuko,Kitagawa 日本 Keio University Updates of perioperative multidisciplinary treatment for surgically resectable esophageal cancer
7. Jesper,Lagergren 英国 Kings College London Diabetes, metformin use, and survival in esophageal cancer: a population-based cohort study
8. Yuko,Kitagawa 日本 Keio University Real-world Evaluation of the Efficacy of Neoadjuvant DCF Over CF in Esophageal Squamous Cell Carcino..
9. Manabu,Muto 日本 Kyoto University Real-world Evaluation of the Efficacy of Neoadjuvant DCF Over CF in Esophageal Squamous Cell Carcino..
10. Hiroya,Takeuchi 日本 Hamamatsu University School of Medicine Real-world Evaluation of the Efficacy of Neoadjuvant DCF Over CF in Esophageal Squamous Cell Carcino..
11. Yuichiro,Doki 日本 Osaka University Real-world Evaluation of the Efficacy of Neoadjuvant DCF Over CF in Esophageal Squamous Cell Carcino..
12. Yuko,Kitagawa 日本 Keio University A nationwide validation of the prognostic impact of pathological response and the distribution of re..
13. Manabu,Muto 日本 Kyoto University A nationwide validation of the prognostic impact of pathological response and the distribution of re..
14. Hiroya,Takeuchi 日本 Hamamatsu University School of Medicine A nationwide validation of the prognostic impact of pathological response and the distribution of re..
15. Yuichiro,Doki 日本 Osaka University A nationwide validation of the prognostic impact of pathological response and the distribution of re..
16. 田捷 中国 北京航空航天大学 PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistanc..
17. 吴一龙 中国 广东省人民医院 PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistanc..
18. 谢东 中国 中国科学院 PES1 reduces CD8+ T cell infiltration and immunotherapy sensitivity via interrupting ILF3..
19. 陈海泉 中国 复旦大学上海医学院 主任医师 Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for local..
20. 陈海泉 中国 复旦大学上海医学院 主任医师 Neoadjuvant therapy with immunoagent (nivolumab) or placebo plus chemotherapy followed by surgery an..